| 1 |
Balestrino R , Schapira AHV . Parkinson disease. Eur J Neurol, 2020, 27: 27- 42.
doi: 10.1111/ene.14108
|
| 2 |
Port RJ , Rumsby M , Brown G , Harrison IF , Amjad A , Bale CJ . People with Parkinson's disease: what symptoms do they most want to improve and how does this change with disease duration?. J Parkinsons Dis, 2021, 11: 715- 724.
doi: 10.3233/JPD-202346
|
| 3 |
Logemann JA , Fisher HB , Boshes B , Blonsky ER . Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord, 1978, 43: 47- 57.
doi: 10.1044/jshd.4301.47
|
| 4 |
Darley FL , Aronson AE , Brown JR . Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res, 1969, 12: 462- 496.
doi: 10.1044/jshr.1203.462
|
| 5 |
Dashtipour K , Tafreshi A , Lee J , Crawley B . Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches. Neurodegener Dis Manag, 2018, 8: 337- 348.
doi: 10.2217/nmt-2018-0021
|
| 6 |
Skrabal D , Rusz J , Novotny M , Sonka K , Ruzicka E , Dusek P , Tykalova T . Articulatory undershoot of vowels in isolated REM sleep behavior disorder and early Parkinson's disease. NPJ Parkinsons Dis, 2022, 8: 137.
doi: 10.1038/s41531-022-00407-7
|
| 7 |
Rusz J , Hlavnička J , Novotný M , Tykalová T , Pelletier A , Montplaisir J , Gagnon JF , Dušek P , Galbiati A , Marelli S , Timm PC , Teigen LN , Janzen A , Habibi M , Stefani A , Holzknecht E , Seppi K , Evangelista E , Rassu AL , Dauvilliers Y , Högl B , Oertel W , St Louis EK , Ferini-Strambi L , Růžička E , Postuma RB , Šonka K . Speech biomarkers in rapid eye movement sleep behavior disorder and Parkinson disease. Ann Neurol, 2021, 90: 62- 75.
doi: 10.1002/ana.26085
|
| 8 |
Silbergleit AK , Schultz L , Hamilton K , LeWitt PA , Sidiropoulos C . Self-perception of voice and swallowing handicap in Parkinson's disease. J Parkinsons Dis, 2021, 11: 2027- 2034.
doi: 10.3233/JPD-212621
|
| 9 |
Hamada T , Higashiyama Y , Saito A , Morihara K , Landin-Romero R , Okamoto M , Kimura K , Miyaji Y , Joki H , Kishida H , Doi H , Ueda N , Takeuchi H , Tanaka F . Qualitative deficits in verbal fluency in Parkinson's disease with mild cognitive impairment: a clinical and neuroimaging study. J Parkinsons Dis, 2021, 11: 2005- 2016.
doi: 10.3233/JPD-202473
|
| 10 |
Rusz J , Krupička R , Vítečková S , Tykalová T , Novotný M , Novák J , Dušek P , Růžička E . Speech and gait abnormalities in motor subtypes of de-novo Parkinson's disease. CNS Neurosci Ther, 2023, 29: 2101- 2110.
doi: 10.1111/cns.14158
|
| 11 |
Tanaka Y , Tsuboi T , Watanabe H , Torii J , Nakatsubo D , Maesawa S , Sato M , Hiraga K , Satake Y , Yokoi K , Hattori M , Kawabata K , Hara K , Yamamoto M , Sobue G , Katsuno M . Instability of speech in Parkinson disease patients with subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord, 2021, 93: 8- 11.
doi: 10.1016/j.parkreldis.2021.10.029
|
| 12 |
Rusz J , Bonnet C , Klempíř J , Tykalová T , Baborová E , Novotný M , Rulseh A , Růžička E . Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. J Neurol, 2015, 262: 992- 1001.
doi: 10.1007/s00415-015-7671-1
|
| 13 |
Prenger MTM , Madray R , Van Hedger K , Anello M , MacDonald PA . Social symptoms of Parkinson's disease. Parkinsons Dis, 2020, 8846544.
|
| 14 |
Read J , Miller N , Kitsou N . Is there an order of loss of sounds in speakers with Parkinson's disease?. Clin Linguist Phon, 2018, 32: 997- 1011.
doi: 10.1080/02699206.2018.1504989
|
| 15 |
Rusz J , Tykalová T , Novotný M , Zogala D , Růžička E , Dušek P . Automated speech analysis in early untreated Parkinson's disease: relation to gender and dopaminergic transporter imaging. Eur J Neurol, 2022, 29: 81- 90.
doi: 10.1111/ene.15099
|
| 16 |
Fabbri M , Guimarães I , Cardoso R , Coelho M , Guedes LC , Rosa MM , Godinho C , Abreu D , Gonçalves N , Antonini A , Ferreira JJ . Speech and voice response to a levodopa challenge in late-stage Parkinson's disease. Front Neurol, 2017, 8: 432.
doi: 10.3389/fneur.2017.00432
|
| 17 |
Im H , Adams S , Abeyesekera A , Pieterman M , Gilmore G , Jog M . Effect of levodopa on speech dysfluency in Parkinson's disease. Mov Disord Clin Pract, 2018, 6: 150- 154.
|
| 18 |
Tykalová T , Rusz J , Čmejla R , Klempíř J , Růžičková H , Roth J , Růžička E . Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study. J Neural Transm (Vienna), 2015, 122: 1135- 1142.
doi: 10.1007/s00702-015-1363-y
|
| 19 |
Cavallieri F , Budriesi C , Gessani A , Contardi S , Fioravanti V , Menozzi E , Pinto S , Moro E , Valzania F , Antonelli F . Dopaminergic treatment effects on dysarthric speech: acoustic analysis in a cohort of patients with advanced Parkinson's disease. Front Neurol, 2021, 11: 616062.
doi: 10.3389/fneur.2020.616062
|
| 20 |
Ho AK , Bradshaw JL , Iansek R . For better or worse: the effect of levodopa on speech in Parkinson's disease. Mov Disord, 2008, 23: 574- 580.
doi: 10.1002/mds.21899
|
| 21 |
Bonnet AM , Loria Y , Saint-Hilaire MH , Lhermitte F , Agid Y . Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?. Neurology, 1987, 37: 1539- 1542.
doi: 10.1212/WNL.37.9.1539
|
| 22 |
Skodda S , Flasskamp A , Schlegel U . Instability of syllable repetition as a marker of disease progression in Parkinson's disease: a longitudinal study. Mov Disord, 2011, 26: 59- 64.
doi: 10.1002/mds.23382
|
| 23 |
Dressel AJ , van der Mijn JC , Aalders IJ , Rinkel RN , van der Vliet HJ . Irinotecan-induced dysarthria. Case Rep Oncol, 2012, 5: 47- 51.
doi: 10.1159/000336156
|
| 24 |
De Keyser K , Santens P , Bockstael A , Botteldooren D , Talsma D , De Vos S , Van Cauwenberghe M , Verheugen F , Corthals P , De Letter M . The relationship between speech production and speech perception deficits in Parkinson's disease. J Speech Lang Hear Res, 2016, 59: 915- 931.
doi: 10.1044/2016_JSLHR-S-15-0197
|
| 25 |
Huang X , Fan H , Li J , Jones JA , Wang EQ , Chen L , Chen X , Liu H . External cueing facilitates auditory-motor integration for speech control in individuals with Parkinson's disease. Neurobiol Aging, 2019, 76: 96- 105.
doi: 10.1016/j.neurobiolaging.2018.12.020
|
| 26 |
Railo H , Nokelainen N , Savolainen S , Kaasinen V . Deficits in monitoring self-produced speech in Parkinson's disease. Clin Neurophysiol, 2020, 131: 2140- 2147.
doi: 10.1016/j.clinph.2020.05.038
|
| 27 |
Liu H , Wang EQ , Metman LV , Larson CR . Vocal responses to perturbations in voice auditory feedback in individuals with Parkinson's disease. PLoS One, 2012, 7: e33629.
doi: 10.1371/journal.pone.0033629
|
| 28 |
Huang X , Chen X , Yan N , Jones JA , Wang EQ , Chen L , Guo Z , Li W , Liu P , Liu H . The impact of Parkinson's disease on the cortical mechanisms that support auditory-motor integration for voice control. Hum Brain Mapp, 2016, 37: 4248- 4261.
doi: 10.1002/hbm.23306
|
| 29 |
Eickhoff SB , Heim S , Zilles K , Amunts K . A systems perspective on the effective connectivity of overt speech production. Philos Trans A Math Phys Eng Sci, 2009, 367: 2399- 2421.
|
| 30 |
Brown S , Laird AR , Pfordresher PQ , Thelen SM , Turkeltaub P , Liotti M . The somatotopy of speech: phonation and articulation in the human motor cortex. Brain Cogn, 2009, 70: 31- 41.
doi: 10.1016/j.bandc.2008.12.006
|
| 31 |
Pinto S , Thobois S , Costes N , Le Bars D , Benabid AL , Broussolle E , Pollak P , Gentil M . Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study. Brain, 2004, 127 (Pt 3): 602- 615.
|
| 32 |
Liotti M , Ramig LO , Vogel D , New P , Cook CI , Ingham RJ , Ingham JC , Fox PT . Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET. Neurology, 2003, 60: 432- 440.
doi: 10.1212/WNL.60.3.432
|
| 33 |
Tankus A , Lustig Y , Fried I , Strauss I . Impaired timing of speech-related neurons in the subthalamic nucleus of Parkinson disease patients suffering speech disorders. Neurosurgery, 2021, 89: 800- 809.
doi: 10.1093/neuros/nyab293
|
| 34 |
Tankus A , Fried I . Degradation of neuronal encoding of speech in the subthalamic nucleus in Parkinson's disease. Neurosurgery, 2019, 84: 378- 387.
doi: 10.1093/neuros/nyy027
|
| 35 |
Arnold C , Gehrig J , Gispert S , Seifried C , Kell CA . Pathomechanisms and compensatory efforts related to Parkinsonian speech. Neuroimage Clin, 2013, 4: 82- 97.
|
| 36 |
Chen Y , Zhu G , Liu D , Liu Y , Yuan T , Zhang X , Jiang Y , Du T , Zhang J . Brain morphological changes in hypokinetic dysarthria of Parkinson's disease and use of machine learning to predict severity. CNS Neurosci Ther, 2020, 26: 711- 719.
doi: 10.1111/cns.13304
|
| 37 |
Jacobson BH , Johnson A , Grywalski C , Silbergleit A , Jacobson G , Benninger MS , Newman CW . The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol, 1997, 6: 66- 70.
|
| 38 |
Lam PK , Chan KM , Ho WK , Kwong E , Yiu EM , Wei WI . Cross-cultural adaptation and validation of the Chinese Voice Handicap Index-10. Laryngoscope, 2006, 116: 1192- 1198.
doi: 10.1097/01.mlg.0000224539.41003.93
|
| 39 |
Nissen LS , Schultz J , Galili J , Printz T , Mehlum CS , Grøntved ÅM , Sorensen JR . Crosscultural adaption and validation of the Danish Voice Handicap Index-10. J Voice, 2021, 35: 661. e7- 661. e11.
|
| 40 |
van Hooren MR , Baijens LW , Vos R , Pilz W , Kuijpers LM , Kremer B , Michou E . Voice-and swallow -related quality of life in idiopathic Parkinson's disease. Laryngoscope, 2016, 126: 408- 414.
doi: 10.1002/lary.25481
|
| 41 |
Enderby P . Frenchay Dysarthria Assessment. Int J Lang Commun Disord, 2011, 15: 165- 173.
|
| 42 |
Ghio A , Giusti L , Blanc E , Pinto S . French adaptation of the "Frenchay Dysarthria Assessment 2" speech intelligibility test. Eur Ann Otorhinolaryngol Head Neck Dis, 2020, 137: 111- 116.
doi: 10.1016/j.anorl.2019.10.007
|
| 43 |
Hijikata N , Kawakami M , Wada A , Ikezawa M , Kaji K , Chiba Y , Ito M , Fujino E , Otsuka T , Liu M . Assessment of dysarthria with Frenchay dysarthria assessment (FDA-2) in patients with Duchenne muscular dystrophy. Disabil Rehabil, 2022, 44: 1443- 1450.
doi: 10.1080/09638288.2020.1800108
|
| 44 |
Yang S , Wang F , Yang L , Xu F , Luo M , Chen X , Feng X , Zou X . The physical significance of acoustic parameters and its clinical significance of dysarthria in Parkinson's disease. Sci Rep, 2020, 10: 11776.
doi: 10.1038/s41598-020-68754-0
|
| 45 |
Pawlukowska W , Szylińska A , Kotlęga D , Rotter I , Nowacki P . Differences between subjective and objective assessment of speech deficiency in Parkinson disease. J Voice, 2018, 32: 715- 722.
doi: 10.1016/j.jvoice.2017.08.018
|
| 46 |
Okada Y , Murata M , Toda T . Effects of levodopa on vowel articulation in patients with Parkinson's disease. Kobe J Med Sci, 2015, 61: E144- E154.
|
| 47 |
LeWitt PA , Fahn S . Levodopa therapy for Parkinson disease: a look backward and forward. Neurology, 2016, 86 (14 Suppl 1): S3- S12.
|
| 48 |
Murakami H , Momma Y , Nohara T , Mori Y , Futamura A , Sugita T , Ishigaki S , Katoh H , Kezuka M , Ono K , Miller MW , Kawamura M . Improvement in language function correlates with gait improvement in drug-naïve Parkinson's disease patients taking dopaminergic medication. J Parkinsons Dis, 2016, 6: 209- 217.
doi: 10.3233/JPD-150702
|
| 49 |
Rusz J , Tykalova T , Novotny M , Zogala D , Sonka K , Ruzicka E , Dusek P . Defining speech subtypes in de novo Parkinson disease: response to long-term levodopa therapy. Neurology, 2021, 97: e2124- e2135.
|
| 50 |
Tykalova T , Novotny M , Ruzicka E , Dusek P , Rusz J . Short-term effect of dopaminergic medication on speech in early-stage Parkinson's disease. NPJ Parkinsons Dis, 2022, 8: 22.
doi: 10.1038/s41531-022-00286-y
|
| 51 |
Schulz GM , Peterson T , Sapienza CM , Greer M , Friedman W . Voice and speech characteristics of persons with Parkinson's disease pre-and post-pallidotomy surgery: preliminary findings. J Speech Lang Hear Res, 1999, 42: 1176- 1194.
doi: 10.1044/jslhr.4205.1176
|
| 52 |
Pinto S , Ozsancak C , Tripoliti E , Thobois S , Limousin-Dowsey P , Auzou P . Treatments for dysarthria in Parkinson's disease. Lancet Neurol, 2004, 3: 547- 556.
doi: 10.1016/S1474-4422(04)00854-3
|
| 53 |
Castrioto A , Lozano AM , Poon YY , Lang AE , Fallis M , Moro E . Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol, 2011, 68: 1550- 1556.
doi: 10.1001/archneurol.2011.182
|
| 54 |
Behroozmand R , Johari K , Kelley RM , Kapnoula EC , Narayanan NS , Greenlee JDW . Effect of deep brain stimulation on vocal motor control mechanisms in Parkinson's disease. Parkinsonism Relat Disord, 2019, 63: 46- 53.
doi: 10.1016/j.parkreldis.2019.03.002
|
| 55 |
Dromey C , Kumar R , Lang AE , Lozano AM . An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord, 2000, 15: 1132- 1138.
doi: 10.1002/1531-8257(200011)15:6<1132::AID-MDS1011>3.0.CO;2-O
|
| 56 |
Ehlen F , Al-Fatly B , Kühn AA , Klostermann F . Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson's disease. PLoS One, 2020, 15: e0244148.
doi: 10.1371/journal.pone.0244148
|
| 57 |
Jorge A , Dastolfo-Hromack C , Lipski WJ , Kratter IH , Smith LJ , Gartner-Schmidt JL , Richardson RM . Anterior sensorimotor subthalamic nucleus stimulation is associated with improved voice function. Neurosurgery, 2020, 87: 788- 795.
doi: 10.1093/neuros/nyaa024
|
| 58 |
Fasano A , Daniele A , Albanese A . Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol, 2012, 11: 429- 442.
doi: 10.1016/S1474-4422(12)70049-2
|
| 59 |
Tanaka Y , Tsuboi T , Watanabe H , Nakatsubo D , Maesawa S , Kato S , Kajita Y , Sato M , Oodake R , Hattori M , Yamamoto M , Wakabayashi T , Katsuno M , Sobue G . Longitudinal speech change after subthalamic nucleus deep brain stimulation in Parkinson's disease patients: a 2-year prospective study. J Parkinsons Dis, 2020, 10: 131- 140.
doi: 10.3233/JPD-191798
|
| 60 |
Limousin P , Foltynie T . Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol, 2019, 15: 234- 242.
doi: 10.1038/s41582-019-0145-9
|
| 61 |
Tanaka Y , Tsuboi T , Watanabe H , Kajita Y , Fujimoto Y , Ohdake R , Yoneyama N , Masuda M , Hara K , Senda J , Ito M , Atsuta N , Horiguchi S , Yamamoto M , Wakabayashi T , Sobue G . Voice features of Parkinson's disease patients with subthalamic nucleus deep brain stimulation. J Neurol, 2015, 262: 1173- 1181.
doi: 10.1007/s00415-015-7681-z
|
| 62 |
Sidtis JJ , Alken AG , Tagliati M , Alterman R , Van Lancker Sidtis D . Subthalamic stimulation reduces vowel space at the initiation of sustained production: implications for articulatory motor control in Parkinson's disease. J Parkinsons Dis, 2016, 6: 361- 370.
doi: 10.3233/JPD-150739
|
| 63 |
Putzke JD , Wharen RE Jr , Wszolek ZK , Turk MF , Strongosky AJ , Uitti RJ . Thalamic deep brain stimulation for tremor-predominant Parkinson's disease. Parkinsonism Relat Disord, 2003, 10: 81- 88.
doi: 10.1016/j.parkreldis.2003.09.002
|
| 64 |
Lizárraga KJ , Gnanamanogaran B , Al-Ozzi TM , Cohn M , Tomlinson G , Boutet A , Elias GJB , Germann J , Soh D , Kalia SK , Hodaie M , Munhoz RP , Marras C , Hutchison WD , Lozano AM , Lang AE , Fasano A . Lateralized subthalamic stimulation for axial dysfunction in Parkinson's disease: a randomized trial. Mov Disord, 2022, 37: 1079- 1087.
doi: 10.1002/mds.28953
|
| 65 |
Marshall DF , Strutt AM , Williams AE , Simpson RK , Jankovic J , York MK . Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol, 2012, 19: 1525- 1531.
doi: 10.1111/j.1468-1331.2012.03759.x
|
| 66 |
Mahlknecht P , Akram H , Georgiev D , Tripoliti E , Candelario J , Zacharia A , Zrinzo L , Hyam J , Hariz M , Foltynie T , Rothwell JC , Limousin P . Pyramidal tract activation due to subthalamic deep brain stimulation in Parkinson's disease. Mov Disord, 2017, 32: 1174- 1182.
doi: 10.1002/mds.27042
|
| 67 |
Piña-Fuentes D , van Dijk JMC , van Zijl JC , Moes HR , van Laar T , Oterdoom DLM , Little S , Brown P , Beudel M . Acute effects of adaptive deep brain stimulation in Parkinson's disease. Brain Stimul, 2020, 13: 1507- 1516.
doi: 10.1016/j.brs.2020.07.016
|
| 68 |
Little S , Tripoliti E , Beudel M , Pogosyan A , Cagnan H , Herz D , Bestmann S , Aziz T , Cheeran B , Zrinzo L , Hariz M , Hyam J , Limousin P , Foltynie T , Brown P . Adaptive deep brain stimulation for Parkinson's disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting. J Neurol Neurosurg Psychiatry, 2016, 87: 1388- 1389.
doi: 10.1136/jnnp-2016-313518
|
| 69 |
Vijiaratnam N , Girges C , Wirth T , Grover T , Preda F , Tripoliti E , Foley J , Scelzo E , Macerollo A , Akram H , Hyam J , Zrinzo L , Limousin P , Foltynie T . Long-term success of low-frequency subthalamic nucleus stimulation for Parkinson's disease depends on tremor severity and symptom duration. Brain Commun, 2021, 3: fcab165.
doi: 10.1093/braincomms/fcab165
|
| 70 |
Zibetti M , Moro E , Krishna V , Sammartino F , Picillo M , Munhoz RP , Lozano AM , Fasano A . Low -frequency subthalamic stimulation in Parkinson's disease: long-term outcome and predictors. Brain Stimul, 2016, 9: 774- 779.
doi: 10.1016/j.brs.2016.04.017
|
| 71 |
Grover T , Georgiev D , Kalliola R , Mahlknecht P , Zacharia A , Candelario J , Hyam J , Zrinzo L , Hariz M , Foltynie T , Limousin P , Jahanshahi M , Tripoliti E . Effect of low versus high frequency subthalamic deep brain stimulation on speech intelligibility and verbal fluency in Parkinson's disease: a double-blind study. J Parkinsons Dis, 2019, 9: 141- 151.
doi: 10.3233/JPD-181368
|
| 72 |
Fabbri M , Zibetti M , Ferrero G , Accornero A , Guimaraes I , Rizzone MG , Romagnolo A , Ferreira JJ , Lopiano L . Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?. Parkinsonism Relat Disord, 2019, 64: 242- 248.
doi: 10.1016/j.parkreldis.2019.04.018
|
| 73 |
Sidiropoulos C , Walsh R , Meaney C , Poon YY , Fallis M , Moro E . Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson's disease. J Neurol, 2013, 260: 2306- 2311.
doi: 10.1007/s00415-013-6983-2
|
| 74 |
Le Goff F , Derrey S , Lefaucheur R , Borden A , Fetter D , Jan M , Wallon D , Maltête D . Decline in verbal fluency after subthalamic nucleus deep brain stimulation in Parkinson's disease: a microlesion effect of the electrode trajectory. J Parkinsons Dis, 2015, 5: 95- 104.
doi: 10.3233/JPD-140443
|
| 75 |
Tsuboi T , Watanabe H , Tanaka Y , Ohdake R , Yoneyama N , Hara K , Nakamura R , Watanabe H , Senda J , Atsuta N , Ito M , Hirayama M , Yamamoto M , Fujimoto Y , Kajita Y , Wakabayashi T , Sobue G . Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry, 2015, 86: 856- 864.
doi: 10.1136/jnnp-2014-308043
|
| 76 |
Tanaka Y , Tsuboi T , Watanabe H , Kajita Y , Nakatsubo D , Fujimoto Y , Ohdake R , Ito M , Atsuta N , Yamamoto M , Wakabayashi T , Katsuno M , Sobue G . Articulation features of Parkinson's disease patients with subthalamic nucleus deep brain stimulation. J Parkinsons Dis, 2016, 6: 811- 819.
doi: 10.3233/JPD-160838
|
| 77 |
Bobin M , Sulzer N , Bründler G , Staib M , Imbach LL , Stieglitz LH , Krauss P , Bichsel O , Baumann CR , Frühholz S . Direct subthalamic nucleus stimulation influences speech and voice quality in Parkinson's disease patients. Brain Stimul, 2024, 17: 112- 124.
doi: 10.1016/j.brs.2024.01.006
|
| 78 |
Moro E , Lozano AM , Pollak P , Agid Y , Rehncrona S , Volkmann J , Kulisevsky J , Obeso JA , Albanese A , Hariz MI , Quinn NP , Speelman JD , Benabid AL , Fraix V , Mendes A , Welter ML , Houeto JL , Cornu P , Dormont D , Tornqvist AL , Ekberg R , Schnitzler A , Timmermann L , Wojtecki L , Gironell A , Rodriguez-Oroz MC , Guridi J , Bentivoglio AR , Contarino MF , Romito L , Scerrati M , Janssens M , Lang AE . Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord, 2010, 25: 578- 586.
doi: 10.1002/mds.22735
|
| 79 |
Dietz J , Noecker AM , McIntyre CC , Mikos A , Bowers D , Foote KD , Okun MS . Stimulation region within the globus pallidus does not affect verbal fluency performance. Brain Stimul, 2013, 6: 248- 253.
doi: 10.1016/j.brs.2012.05.011
|
| 80 |
Chiu SY , Tsuboi T , Hegland KW , Herndon NE , Shukla AW , Patterson A , Almeida L , Foote KD , Okun MS , Ramirez-Zamora A . Dysarthria and speech intelligibility following Parkinson's disease globus pallidus internus deep brain stimulation. J Parkinsons Dis, 2020, 10: 1493- 1502.
doi: 10.3233/JPD-202246
|
| 81 |
Mu L , Sobotka S , Chen J , Su H , Sanders I , Adler CH , Shill HA , Caviness JN , Samanta JE , Beach TG , Arizona Parkinson's Disease Consortium . Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol, 2012, 71: 520- 530.
doi: 10.1097/NEN.0b013e318258381b
|
| 82 |
Berke GS , Gerratt B , Kreiman J , Jackson K . Treatment of Parkinson hypophonia with percutaneous collagen augmentation. Laryngoscope, 1999, 109: 1295- 1299.
doi: 10.1097/00005537-199908000-00020
|
| 83 |
Krishna V , Fishman PS , Eisenberg HM , Kaplitt M , Baltuch G , Chang JW , Chang WC , Martinez Fernandez R , Del Alamo M , Halpern CH , Ghanouni P , Eleopra R , Cosgrove R , Guridi J , Gwinn R , Khemani P , Lozano AM , McDannold N , Fasano A , Constantinescu M , Schlesinger I , Dalvi A , Elias WJ . Trial of globus pallidus focused ultrasound ablation in Parkinson's disease. N Engl J Med, 2023, 388: 683- 693.
doi: 10.1056/NEJMoa2202721
|
| 84 |
Chua MMJ , Blitz SE , Ng PR , Segar DJ , McDannold NJ , White PJ , Christie S , Hayes MT , Rolston JD , Cosgrove GR . Focused ultrasound thalamotomy for tremor in Parkinson's disease: outcomes in a large, prospective cohort. Mov Disord, 2023, 38: 1962- 1967.
doi: 10.1002/mds.29569
|
| 85 |
Segar DJ , Lak AM , Lee S , Harary M , Chavakula V , Lauro P , McDannold N , White J , Cosgrove GR . Lesion location and lesion creation affect outcomes after focused ultrasound thalamotomy. Brain, 2021, 144: 3089- 3100.
doi: 10.1093/brain/awab176
|
| 86 |
Brabenec L , Klobusiakova P , Simko P , Kostalova M , Mekyska J , Rektorova I . Non-invasive brain stimulation for speech in Parkinson's disease: a randomized controlled trial. Brain Stimul, 2021, 14: 571- 578.
doi: 10.1016/j.brs.2021.03.010
|
| 87 |
Schulz G , Halpern A , Spielman J , Ramig L , Panzer I , Sharpley A , Freeman K . Single word intelligibility of individuals with Parkinson's disease in noise: pre-specified secondary outcome variables from a randomized control trial (RCT) comparing two intensive speech treatments (LSVT LOUD vs. LSVT ARTIC). Brain Sci, 2021, 11: 857.
doi: 10.3390/brainsci11070857
|
| 88 |
Brabenec L , Simko P , Sejnoha Minsterova A , Kostalova M , Rektorova I . Repetitive transcranial magnetic stimulation for hypokinetic dysarthria in Parkinson's disease enhances white matter integrity of the auditory-motor loop. Eur J Neurol, 2023, 30: 881- 886.
doi: 10.1111/ene.15665
|
| 89 |
Dai G , Wang M , Li Y , Guo Z , Jones JA , Li T , Chang Y , Wang EQ , Chen L , Liu P , Chen X , Liu H . Continuous theta burst stimulation over left supplementary motor area facilitates auditory-vocal integration in individuals with Parkinson's disease. Front Aging Neurosci, 2022, 14: 948696.
doi: 10.3389/fnagi.2022.948696
|
| 90 |
Moustafa AA , Chakravarthy S , Phillips JR , Gupta A , Keri S , Polner B , Frank MJ , Jahanshahi M . Motor symptoms in Parkinson's disease: a unified framework. Neurosci Biobehav Rev, 2016, 68: 727- 740.
doi: 10.1016/j.neubiorev.2016.07.010
|
| 91 |
Ramig L , Halpern A , Spielman J , Fox C , Freeman K . Speech treatment in Parkinson's disease: randomized controlled trial (RCT). Mov Disord, 2018, 33: 1777- 1791.
doi: 10.1002/mds.27460
|
| 92 |
Baumann A , Nebel A , Granert O , Giehl K , Wolff S , Schmidt W , Baasch C , Schmidt G , Witt K , Deuschl G , Hartwigsen G , Zeuner KE , van Eimeren T . Neural correlates of hypokinetic dysarthria and mechanisms of effective voice treatment in Parkinson disease. Neurorehabil Neural Repair, 2018, 32: 1055- 1066.
doi: 10.1177/1545968318812726
|
| 93 |
Yuan F , Guo X , Wei X , Xie F , Zheng J , Huang Y , Huang Z , Chang Z , Li H , Guo Y , Chen J , Guo J , Tang B , Deng B , Wang Q . Lee Silverman voice treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis. Eur J Neurol, 2020, 27: 1957- 1970.
doi: 10.1111/ene.14399
|
| 94 |
Levy ES , Moya-Galé G , Chang YHM , Freeman K , Forrest K , Brin MF , Ramig LA . The effects of intensive speech treatment on intelligibility in Parkinson's disease: a randomised controlled trial. EClinicalMedicine, 2020, 24: 100429.
doi: 10.1016/j.eclinm.2020.100429
|
| 95 |
Narayana S , Franklin C , Peterson E , Hunter EJ , Robin DA , Halpern A , Spielman J , Fox PT , Ramig LO . Immediate and long-term effects of speech treatment targets and intensive dosage on Parkinson's disease dysphonia and the speech motor network: randomized controlled trial. Hum Brain Mapp, 2022, 43: 2328- 2347.
doi: 10.1002/hbm.25790
|
| 96 |
Li Y , Tan M , Fan H , Wang EQ , Chen L , Li J , Chen X , Liu H . Neurobehavioral effects of LSVT® LOUD on auditory-vocal integration in Parkinson's disease: a preliminary study. Front Neurosci, 2021, 15: 624801.
doi: 10.3389/fnins.2021.624801
|
| 97 |
Theodoros D . Telerehabilitation for communication and swallowing disorders in Parkinson's disease. J Parkinsons Dis, 2021, 11 (s1): S65- S70.
doi: 10.3233/JPD-202414
|
| 98 |
Hireš M , Gazda M , Drotár P , Pah ND , Motin MA , Kumar DK . Convolutional neural network ensemble for Parkinson's disease detection from voice recordings. Comput Biol Med, 2022, 141: 105021.
doi: 10.1016/j.compbiomed.2021.105021
|